Abstract:Nanocarriers, more commonly called nanoparticles (NPs), have found increasing use as delivery vehicles which increase the oral bioavailability of poorly water-soluble and peptide therapeutics. Therapeutic bioavailability is commonly assessed by measuring plasma concentrations that reflect the absorption kinetics. This bioavailability is a convolution of the gastrointestinal distribution of the NP vehicle, the release rate of the encapsulated therapeutic cargo, and the absorption-metabolism-distribution kinetics of the released therapeutic. The spatiotemporal distribution of the NP vehicle in the gastrointestinal tract is not well studied and is a buried parameter in PK studies used to measure the effectiveness of an NP formulation. This work is a study of the intestinal distribution and fate of orally dosed NPs in male CD-1 mice over 24 h. NPs have identical hydrophobic cores - composed of poly(styrene) homopolymer, a naphthalocyanine dye, and oleate-coated europium oxide colloids - with one of four different surface stabilizers: neutral poly(styrene)-block-poly(ethylene glycol) (PS-b-PEG), moderately negative hydroxypropyl methylcellulose acetate succinate (HPMCAS), highly negative poly(styrene)-block-poly(acrylic acid) (PS-b-PAA), and highly cationic adsorbed chitosan HCl on PS-b-PAA stabilized NPs. NP hydrodynamic diameters are all below 200 nm, with some variation attributable to the molecular properties of the stabilizing polymer. The encapsulated hydrophobic europium oxide colloids do not release soluble europium ions, enabling the use of highly sensitive inductively coupled plasma mass spectrometry (ICP-MS) to detect NP concentrations in digested biological tissues. Highly anionically-charged PAA and cationically-charged chitosan stabilized NPs showed statistically significant increased retention compared to the neutral PEG-stabilized NPs at p < 0.05 significance and (1-β) > 0.95 power. HPMCAS-stabilized NPs showed statistically insignificant greater retention than PEG-stabilized NPs, and all NP formulations showed clearance from the intestines within 24 h. Different surface charges preferentially reside in different segments of the intestines, where cationic chitosan-stabilized NPs showed increased retention in the small intestines (ileum) and anionic PAA-stabilized NPs in the large intestines (caecum and colon). Modifying the surface charge of a NP can be used to modulate mucoadhesion, total retention, and intestinal segment specific retention, which enables the rational design of delivery vehicles that maximize residence times in appropriate locations.

Effects of Ph-Sensitive Nanoparticles Prepared with Different Polymers on the Distribution, Adhesion and Transition of Rhodamine 6g in the Gut of Rats

pH-triggered cancer-targeting polymers: From extracellular accumulation to intracellular release

Size-dependent Absorption Mechanism of Polymeric Nanoparticles for Oral Delivery of Protein Drugs

Intestinal distribution of anionic, cationic, and neutral polymer-stabilized nanocarriers measured with a lanthanide (europium) tracer assay

Distribution, Transition, Adhesion and Release of Insulin Loaded Nanoparticles in the Gut of Rats.

pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.

Synthesis and Characterization of pH Sensitive Nanoparticles

A facile way to fabricate pH-sensitive charge-conversion polymeric nanoparticles with tunable pH conversion point

Dually Responsive Nanoparticles for Drug Delivery Based on Quaternized Chitosan

Characterization and performance evaluation of pH-sensitive drug delivery of nanoparticles prepared using green method with coating and capsule structure

Research on the fate of polymeric nanoparticles in the process of the intestinal absorption based on model nanoparticles with various characteristics: size, surface charge and pro-hydrophobics

Preparation, sustained release and cell imaging studies of rhodamine 6G@-nido-carborane fluorescent polymer

Application of Polyhydroxyalkanoates Nanoparticles As Intracellular Sustained Drug-Release Vectors

Nano-Carriers Based On Ph-Sensitive Star-Shaped Copolymers For Drug-Controlled Release

Effective pH-responsive nanocarrier based on the anisotropic surfaces of halloysite nanotubes for controlled drug release

Ph-Responsive Nanofiber Membranes for Superior Controlled Release of Poorly Water-Soluble Drug and Its Release Mechanism Study

Application of Mesoscale Simulation to Explore the Aggregate Morphology of Ph-Sensitive Nanoparticles Used As the Oral Drug Delivery Carriers under Different Conditions

Controlling Cellular Uptake of Nanoparticles with Ph-Sensitive Polymers

Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles.

pH-responsive mesoporous silica nanocarriers based on layer-by-layer self-assembly.

The effect of surface charge on oral absorption of polymeric nanoparticles